Comparison of the effect of echinophora platyloba and fennilin on the severity of premenstrual syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT138810263078N1

Enrollment

Registered

2010-05-20

Start date

2008-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Recieving the fenilin. Intervention 2: Recieving the Echinophora Platiloba. Intervention 3: Recieving placebo.

Treatment - Drugs

Placebo

Recieving the fenilin

Recieving the Echinophora Platiloba

Recieving placebo

Eligibility

Sex/Gender

Female

Age

18 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1) Students with moderate to severe premenstural syndrome 2) Age between 18-25 3) Not married

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measured severity of premenstrual syndrome. Timepoint: Two month befores intervention and 2 month after intervention given. Method of measurement: DRSP questionnaire.	—

Secondary

Measure	Time frame
Measured severity of premenstrual syndrome. Timepoint: every month for 4 months. Method of measurement: using the information records.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Delaram

Shahrekord University of medical sciences

masoumehdelaram@yahoo.com; mdelaram@skums.ac.ir+98 38 1333 5648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026